93 research outputs found

    In the eye of the beholder: mothers' perceptions of poor neighborhoods as places to raise children

    Full text link
    This study explores how mothers facing similar neighborhood conditions evaluate their neighborhoods as places to raise children. The authors relied upon a triangulation of methods, using both quantitative and qualitative methodologies, with a sample of 91 low-income mothers. Content analysis of qualitative interviews revealed that mothers often hold divergent views about the quality of the same or similar neighborhoods. Mothers' overall neighborhood perceptions were influenced by several specific indicators, including social interaction, collective efficacy, fear of crime, personal victimization, and neighborhood incivilities. Moreover, mothers' subjective neighborhood perceptions were related to their parenting strategies. This study thus underscores the importance of not solely relying on “objective” neighborhood criteria such as census data, but of also attending to residents' subjective perceptions of their own neighborhoods. © 2010 Wiley Periodicals, Inc.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/69195/1/20372_ftp.pd

    The state of the evidence base for psychodynamic psychotherapy for children and adolescents

    Get PDF
    This article reviews outcomes of psychodynamic psychotherapy (PP) for children and adolescents reported in articles identified by a comprehensive review of the literature on treatment evaluations of psychological and medical interventions for mental disorders in pediatric populations. The review identified 48 reports based on 33 studies. While there is evidence of substantial clinical gains associated with PP, in almost all the studies, when contrasted with family-based interventions, PP fares no better and appears to produce outcomes with some delay relative to family-based therapies. Further rigorous evaluations are needed, but evidence to date suggests that the context in which PP is delivered should be extended from the traditional context of individual therapy and parents should be included in the treatment of children

    Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Get PDF
    Soft tissue sarcomas (STSs) comprise ∼80 entities defined by the World Health Organization (WHO) classification based on a combination of distinctive morphological, immunohistochemical and molecular features.1 These ESMO–EURACAN–GENTURIS (European Society for Medical Oncology; European Reference Network for Rare Adult Solid Cancers; European Reference Network for Genetic Tumour Risk Syndromes) Clinical Practice Guidelines (CPGs) will cover STSs, with the exception of gastrointestinal stromal tumours (GISTs) that are covered in the ESMO–EURACAN–GENTURIS GIST CPGs.2 EURACAN and GENTURIS are the European Reference Networks connecting European institutions, appointed by their governments, to cover rare adult solid cancers and genetic cancer risk syndromes, respectively. Extraskeletal Ewing sarcoma, round cell sarcoma with EWSR1-non-ETS fusion and sarcomas with CIC rearrangements and BCOR genetic alterations are covered by the ESMO–EURACAN–GENTURIS–ERN PaedCan (European Reference Network for Paediatric Oncology) bone sarcomas CPG.3 Kaposi's sarcoma, embryonal and alveolar rhabdomyosarcoma are not discussed in this manuscript, while pleomorphic rhabdomyosarcoma is viewed as a high-grade, adult-type STS. Finally, extraskeletal osteosarcoma is also a considered a high-grade STS, whose clinical resemblance with osteosarcoma of bone is doubtful. The methodology followed during the consensus meeting is specified at the end of the manuscript in a dedicated paragraph

    Roy LeGrange Underhill K1913 Scrapbook

    Get PDF
    https://digital.kenyon.edu/scrapbooks/1144/thumbnail.jp

    Pharmacokinetics of cisapride in normal healthy cats and recommended oral dosing regimen

    No full text
    Due to the character of the original source materials and the nature of batch digitization, quality control issues may be present in this document. Please report any quality issues you encounter to [email protected], referencing the URI of the item.Includes bibliographical references.Issued also on microfiche from Lange Micrographics.The purpose of this study was to determine the disposition of cisapride in cats following oral (PO) and intravenous (IV) administration of a single dose and the bioavailability (F) of the drug when administered as an oral capsule. 7 cats each were treated with either 1 mg/kg (IV) or 2 mg/kg (PO) after a 24 hour fast. Blood samples were collected intermittently for 36 hours following administration. Cats were studied in pairs using a random crossover design in which a cat receiving an oral dose was paired with one receiving an intravenous dose. Cisapride was detected with an HPLC assay validated for cat plasma. Drug concentration versus time curves were subjected to standard pharmacokinetic analysis. Disposition parameters were compared between PO and IV groups. Following IV administration, extrapolated peak cisapride concentration, Co, was 421.30 + 155.37 ng/ml; clearance was 0.015 + 0.0067 ml/min*kg; mean residence time (MRT) was 6.36 + 4.21 hr; and volume of distribution (Vdss) was 4.50 + 1.36 ml/kg. Cmax for the oral capsule was 73.32 + 16.59 ng/ml, MRT was 8.32 + 4.47 hr, and F was 29.0 + 22.6%. Elimination half-life was similar for both the oral and intravenous routes (T1/2(lv) = 5.19 + 3.77 hr, Tk(po) = 5.27 -+ 3.16 hr) . All cats tolerated all doses with no apparent adverse effects. Based on these data an oral dose of 1 mg/kg given every 8 hours should maintain an average concentration at steady state that lies within the published therapeutic range for people
    corecore